Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 201 | MDTMedtronicHealthcare | $89.50 | −0.5% | +2.7% | −15.0% | $114.48B |
| 202 | BCAXBicara TherapeuticsHealthcare | $18.80 | −24.3% | +2.3% | −38.2% | $1.24B |
| 203 | REGNRegeneron PharmaceuticalsHealthcare | $752.25 | −6.9% | +2.0% | −11.7% | $77.45B |
| 204 | VKTXViking TherapeuticsHealthcare | $33.03 | −2.5% | +1.6% | −21.6% | $4.11B |
| 205 | OCULOcular TherapeutixHealthcare | $7.66 | −29.3% | +1.4% | −52.5% | $1.68B |
| 206 | MDGLMadrigal PharmaceuticalsHealthcare | $517.04 | −4.9% | +1.2% | −14.2% | $11.95B |
| 207 | RMDResMedHealthcare | $222.10 | −5.8% | +0.7% | −21.6% | $32.04B |
| 208 | PTCTPTC TherapeuticsHealthcare | $65.95 | −8.2% | −0.3% | −26.4% | $5.50B |
| 209 | MIRMMirum PharmaceuticalsHealthcare | $87.96 | −11.8% | −0.5% | −31.6% | $5.71B |
| 210 | PRVAPrivia Health GroupHealthcare | $19.87 | −4.7% | −0.7% | −29.3% | $2.54B |
| 211 | ACADAcadia PharmaceuticalsHealthcare | $20.53 | −30.9% | −1.1% | −32.8% | $3.54B |
| 212 | SVRASavaraHealthcare | $5.07 | −7.7% | −1.4% | −26.9% | $1.04B |
| 213 | PRAXPraxis Precision MedicinesHealthcare | $285.65 | −22.3% | −1.5% | −26.1% | $7.98B |
| 214 | ABTAbbott LaboratoriesHealthcare | $100.98 | −9.5% | −2.9% | −25.0% | $174.73B |
| 215 | ELANElanco Animal Health IncorporatedHealthcare | $22.45 | −8.3% | −2.9% | −16.4% | $11.22B |
| 216 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per shareHealthcare | $23.73 | −13.5% | −3.5% | −21.6% | $3.81B |
| 217 | GEHCGE HealthCare TechnologiesHealthcare | $66.78 | −7.9% | −3.5% | −24.3% | $30.16B |
| 218 | UHSUniversal Health ServicesHealthcare | $177.48 | +2.8% | −3.6% | −27.3% | $10.46B |
| 219 | STESTERISHealthcare | $211.00 | −9.4% | −3.8% | −21.5% | $20.57B |
| 220 | BBIOBridgeBio PharmaHealthcare | $66.61 | −15.3% | −4.4% | −26.1% | $13.02B |
| 221 | IRTCiRhythm HoldingsHealthcare | $112.60 | −3.2% | −4.7% | −40.5% | $3.71B |
| 222 | DYNDyne TherapeuticsHealthcare | $16.34 | −37.4% | −4.7% | −39.0% | $3.05B |
| 223 | PENPenumbraHealthcare | $319.18 | −0.6% | −4.8% | −11.2% | $12.57B |
| 224 | IDXXIdexx LaboratoriesHealthcare | $529.06 | −2.9% | −5.2% | −31.0% | $41.68B |
| 225 | ERASErascaHealthcare | $14.13 | −27.5% | −5.6% | −37.1% | $4.94B |
| 226 | SRPTSarepta Therapeutics,Healthcare | $18.80 | −12.9% | −5.9% | −23.1% | $1.99B |
| 227 | INVAInnovivaHealthcare | $21.23 | +1.3% | −6.3% | −12.4% | $1.53B |
| 228 | HROWHarrowHealthcare | $31.60 | −18.0% | −6.6% | −42.3% | $1.18B |
| 229 | SMMTSummit TherapeuticsHealthcare | $15.48 | +8.0% | −6.6% | −41.3% | $12.35B |
| 230 | UTHRUnited TherapeuticsHealthcare | $485.54 | −8.0% | −7.1% | −18.6% | $20.83B |
| 231 | NTLAIntellia TherapeuticsHealthcare | $11.42 | −12.9% | −7.7% | −59.2% | $1.60B |
| 232 | ATECAlphatec HoldingsHealthcare | $10.05 | +5.0% | −8.1% | −55.7% | $1.55B |
| 233 | HCAHCA HealthcareHealthcare | $432.60 | +3.2% | −8.3% | −20.6% | $93.66B |
| 234 | ISRGIntuitive SurgicalHealthcare | $414.79 | +13.0% | −8.4% | −30.0% | $146.54B |
| 235 | BCRXBioCryst PharmaceuticalsHealthcare | $8.47 | −14.2% | −9.2% | −23.8% | $2.16B |
| 236 | SUPNSupernus PharmaceuticalsHealthcare | $44.60 | +0.9% | −9.9% | −21.8% | $2.60B |
| 237 | GMEDGLOBUS MEDICALHealthcare | $74.78 | −9.4% | −10.7% | −22.8% | $10.04B |
| 238 | IRMDiRadimedHealthcare | $86.66 | −0.4% | −11.0% | −17.6% | $1.11B |
| 239 | ANABAnaptysBioHealthcare | $50.80 | −11.3% | −11.5% | −27.7% | $1.52B |
| 240 | MAZEMaze TherapeuticsHealthcare | $26.85 | −6.1% | −11.6% | −48.2% | $1.49B |
| 241 | COGTCogent BiosciencesHealthcare | $31.86 | −14.1% | −11.7% | −25.6% | $5.53B |
| 242 | NKTRNektar TherapeuticsHealthcare | $60.40 | −19.0% | −12.0% | −39.8% | $2.06B |
| 243 | ENSGThe Ensign GroupHealthcare | $176.36 | +1.6% | −12.1% | −18.3% | $10.28B |
| 244 | ALGNAlign TechnologyHealthcare | $145.00 | −8.7% | −12.9% | −26.6% | $10.30B |
| 245 | CDRECadre HoldingsHealthcare | $26.06 | −16.2% | −13.0% | −43.4% | $1.12B |
| 246 | MDLNMedlineHealthcare | $35.07 | +1.2% | −15.2% | −29.8% | $30.77B |
| 247 | SYKStrykerHealthcare | $275.31 | −14.5% | −15.9% | −29.1% | $105.60B |
| 248 | OPCHOption Care HealthHealthcare | $22.90 | −4.5% | −16.0% | −37.4% | $3.43B |
| 249 | VERAVera TherapeuticsHealthcare | $32.50 | −6.1% | −16.4% | −41.6% | $2.34B |
| 250 | TMDXTransMedics GroupHealthcare | $82.73 | −9.8% | −16.5% | −45.0% | $2.87B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.